BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 24809789)

  • 1. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.
    Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G
    Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch from aprotinin to ε-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery.
    Martin K; Gertler R; Liermann H; Mayr NP; MacGuill M; Schreiber C; Vogt M; Tassani P; Wiesner G
    Br J Anaesth; 2011 Dec; 107(6):934-9. PubMed ID: 21857014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery.
    Williams GD; Bratton SL; Riley EC; Ramamoorthy C
    J Cardiothorac Vasc Anesth; 1999 Jun; 13(3):304-8. PubMed ID: 10392682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antifibrinolytic prophylaxis on postoperative outcomes in patients undergoing cardiac operations.
    Koul A; Ferraris V; Davenport DL; Ramaiah C
    Int Surg; 2012; 97(1):34-42. PubMed ID: 23101999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery.
    Casati V; Guzzon D; Oppizzi M; Cossolini M; Torri G; Calori G; Alfieri O
    Ann Thorac Surg; 1999 Dec; 68(6):2252-6; discussion 2256-7. PubMed ID: 10617012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
    Sniecinski RM; Chen EP; Makadia SS; Kikura M; Bolliger D; Tanaka KA
    J Cardiothorac Vasc Anesth; 2010 Dec; 24(6):959-63. PubMed ID: 20430647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood loss and transfusion requirements with epsilon-aminocaproic acid use during cranial vault reconstruction surgery.
    Thompson ME; Saadeh C; Watkins P; Nagy L; Demke J
    J Clin Anesth; 2017 Feb; 36():153-157. PubMed ID: 28183556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
    Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use.
    Basta MN; Stricker PA; Taylor JA
    Pediatr Surg Int; 2012 Nov; 28(11):1059-69. PubMed ID: 22940882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
    Laupacis A; Fergusson D
    Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods to decrease blood loss and transfusion requirements for liver transplantation.
    Gurusamy KS; Pissanou T; Pikhart H; Vaughan J; Burroughs AK; Davidson BR
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009052. PubMed ID: 22161443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials.
    Carless PA; Moxey AJ; Stokes BJ; Henry DA
    BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.